PE-conjugated Anti-CD40(mitazalimab biosimilar) mAb

PE-conjugated Anti-CD40(mitazalimab biosimilar) mAb
Artikelnummer
DMABME100573P-100
Verpackungseinheit
100 test
Hersteller
DIMA Biotechnology

Verfügbarkeit: wird geladen...
Preis wird geladen...
Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Description: PE-conjugated Anti-CD40(mitazalimab biosimilar) mAb

Storage & Shipping: Store at 2°C-8°C fo 6 months

Formulation & Reconstitution: Liquid,PBS with 0.05% Proclin300, 599% BSA

Target: CD40

Uniprot ID: P25942

Usage: Research use only

Recommended Dilutions: Flow Cyt 1:100

Common Name: ADC 1013ADC-1013ADC1013JNJ 7107JNJ7107JNJ-7107JNJ-64457107JNJ64457107JNJ 64457107Vanalimab

Guarantee: 6 months from date of dispatch
Mehr Informationen
Artikelnummer DMABME100573P-100
Hersteller DIMA Biotechnology
Hersteller Artikelnummer BME100573P-100
Verpackungseinheit 100 test
Mengeneinheit STK
Reaktivität Human
Methode Flow Cytometry
Isotyp IgG1
Konjugat Conjugated, PE (Phycoerythrin)
Produktinformation (PDF) Download
MSDS (PDF) Download